Literature DB >> 12452531

Dopamine D1 and D2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking.

Jong Y Bahk1, Shupeng Li, Moon S Park, Myeong O Kim.   

Abstract

Nicotine, the toxic substance that is exclusively absorbed from smoking, produces a wide array of behavior and collectively propels drug-seeking behaviors when abused. The neurotransmitter dopamine (DA) is important in the reward and reinforcing properties of many addictive drugs: however, the effect of nicotine by cigarette smoking itself on the expression of DA receptors in the caudate-putamen (CPu), nucleus accumbens (NAc) and olfactory tubercle (OTu) has not been elucidated completely. Hence, the effects of smoking and nicotine on DA receptors need to be defined. In this research, the effect of smoking and nicotine addiction on the DA D1 and D2 receptors in the rat CPu, NAc and OTu were studied. Adult male Spraque-Dawley (S.D., n=50) rats were administered with cigarette smoke (passive inhaled for 10 min and 1 h, 500 ml x 3 times/day, 4 weeks) and nicotine (oral, 3 mg/day). DA D1 and D2 receptor mRNA levels were determined by in situ hybridization and RNase protection assay (RPA). In the smoking groups (10 min and 1 h), DA D1 and D2 receptor mRNA greatly increased in the CPu and NAc, and most of all in the NAc. The nicotine treated group showed increased expression of DA D1 and D2 receptor mRNA too, but statistically less than in the smoking group. In the smoking group, DA D1 and D2 receptor mRNA levels were significantly higher in the CPu and NAc than in the nicotine group (P<.01). These results suggest that smoking and nicotine administration both influence DA receptor mRNAs in the CPu, NAc and OTu, in terms of up-regulation. The up-regulation was much more evident in the smoking group than in the nicotine group. In conclusion, we believe that smoking up-regulate the DA receptor mRNA expression significantly higher in rat CPu and NAc than nicotine but only a little bit higher in OTu.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452531     DOI: 10.1016/s0278-5846(02)00243-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  17 in total

1.  Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway.

Authors:  Benjamin N Greenwood; Teresa E Foley; Tony V Le; Paul V Strong; Alice B Loughridge; Heidi E W Day; Monika Fleshner
Journal:  Behav Brain Res       Date:  2010-11-09       Impact factor: 3.332

2.  C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency.

Authors:  Leslie K Jacobsen; Kenneth R Pugh; W Einar Mencl; Joel Gelernter
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

Review 3.  Addicted to palatable foods: comparing the neurobiology of Bulimia Nervosa to that of drug addiction.

Authors:  Natalie A Hadad; Lori A Knackstedt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-06       Impact factor: 4.530

4.  What are candidate biobehavioral mechanisms underlying the association between secondhand smoke exposure and mental health?

Authors:  Frank C Bandiera
Journal:  Med Hypotheses       Date:  2011-09-07       Impact factor: 1.538

Review 5.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

6.  DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.

Authors:  Wonho Lee; Riju Ray; Andrew W Bergen; Gary E Swan; Paul Thomas; Rachel F Tyndale; Neal L Benowitz; Caryn Lerman; David V Conti
Journal:  Pharmacogenet Genomics       Date:  2012-07       Impact factor: 2.089

Review 7.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

8.  Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder.

Authors:  Tanya E Froehlich; Bruce P Lanphear; Peggy Auinger; Richard Hornung; Jeffery N Epstein; Joe Braun; Robert S Kahn
Journal:  Pediatrics       Date:  2009-11-23       Impact factor: 7.124

9.  Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humans.

Authors:  Leonard H Epstein; Jennifer L Temple; Brad J Neaderhiser; Robbert J Salis; Richard W Erbe; John J Leddy
Journal:  Behav Neurosci       Date:  2007-10       Impact factor: 1.912

Review 10.  Animal models and treatments for addiction and depression co-morbidity.

Authors:  Neil E Paterson; Athina Markou
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.